Citigroup’s Rubius Therapeutics, Inc RUBY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,342
| Closed | -$231 | – | 5167 |
|
|
2022
Q4 | $231 | Buy |
1,342
+56
| +4% | +$10 | ﹤0.01% | 4787 |
|
|
2022
Q3 | $1K | Sell |
1,286
-692
| -35% | -$538 | ﹤0.01% | 4913 |
|
|
2022
Q2 | $2K | Sell |
1,978
-30,202
| -94% | -$30.5K | ﹤0.01% | 5149 |
|
|
2022
Q1 | $177K | Sell |
32,180
-105,171
| -77% | -$578K | ﹤0.01% | 3459 |
|
|
2021
Q4 | $1.33M | Buy |
137,351
+42,400
| +45% | +$411K | ﹤0.01% | 2284 |
|
|
2021
Q3 | $1.7M | Sell |
94,951
-90,829
| -49% | -$1.62M | ﹤0.01% | 2027 |
|
|
2021
Q2 | $4.54M | Buy |
185,780
+179,677
| +2,944% | +$4.39M | ﹤0.01% | 1494 |
|
|
2021
Q1 | $162K | Sell |
6,103
-4,850
| -44% | -$129K | ﹤0.01% | 3470 |
|
|
2020
Q4 | $83K | Buy |
10,953
+3,278
| +43% | +$24.8K | ﹤0.01% | 3805 |
|
|
2020
Q3 | $38K | Sell |
7,675
-9,276
| -55% | -$45.9K | ﹤0.01% | 3624 |
|
|
2020
Q2 | $101K | Buy |
16,951
+739
| +5% | +$4.4K | ﹤0.01% | 3453 |
|
|
2020
Q1 | $72K | Buy |
16,212
+1,637
| +11% | +$7.27K | ﹤0.01% | 3526 |
|
|
2019
Q4 | $138K | Buy |
14,575
+10,747
| +281% | +$102K | ﹤0.01% | 3343 |
|
|
2019
Q3 | $30K | Sell |
3,828
-7,787
| -67% | -$61K | ﹤0.01% | 4050 |
|
|
2019
Q2 | $182K | Buy |
11,615
+1,326
| +13% | +$20.8K | ﹤0.01% | 3260 |
|
|
2019
Q1 | $186K | Buy |
+10,289
| New | +$186K | ﹤0.01% | 3182 |
|
|
2018
Q4 | – | Sell |
-3,400
| Closed | -$82K | – | 5149 |
|
|
2018
Q3 | $82K | Buy |
+3,400
| New | +$82K | ﹤0.01% | 3731 |
|